# Effect of Oral Supplementation With Curcumin on Insulin Sensitivity in Subjects With Prediabetes

Study · id `cardio:ct-nct03917784` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03917784](<https://clinicaltrials.gov/study/NCT03917784>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT03917784

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 142 participants.

## Technical summary

Registry record NCT03917784. Randomized; triple masking; primary purpose prevention. Start 2019-02-25 (actual); primary completion 2019-11-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 142 participants (planned count; ClinicalTrials.gov record NCT03917784, source copy `cardio:ctgov-nct03917784-2019-04-17`, retrieved 2026-11-18)
- Started: 2019-02-25 (actual) (ClinicalTrials.gov record NCT03917784, source copy `cardio:ctgov-nct03917784-2019-04-17`, retrieved 2026-11-18)
- Primary completion: 2019-11-30 (anticipated) (ClinicalTrials.gov record NCT03917784, source copy `cardio:ctgov-nct03917784-2019-04-17`, retrieved 2026-11-18)
- Completion: 2020-02-28 (anticipated) (ClinicalTrials.gov record NCT03917784, source copy `cardio:ctgov-nct03917784-2019-04-17`, retrieved 2026-11-18)
- Countries: Mexico (ClinicalTrials.gov record NCT03917784, source copy `cardio:ctgov-nct03917784-2019-04-17`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03917784-2019-04-17`, retrieved 2026-11-18)

## The registry's words

- Brief title: Effect of Oral Supplementation With Curcumin on Insulin Sensitivity in Subjects With Prediabetes
- Condition: PreDiabetes
- Intervention (Drug): Curcumin
- Intervention (Drug): Starch
- Lead sponsor: Hospital General de México Dr. Eduardo Liceaga
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Prediabetes (`cardio:prediabetes`)

## Provenance

Content hash: 630968e003d0aa9b8665286363e0e629dc9a9c4987f538f880ab9e1b0c60b362
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
